Home > National Drug Code (NDC) > Ceftazidime

Ceftazidime - 25021-127-20 - (ceftazidime)

Alphabetical Index


Drug Information of Ceftazidime

Product NDC: 25021-127
Proprietary Name: Ceftazidime
Non Proprietary Name: ceftazidime
Active Ingredient(s): 1    g/1 & nbsp;   ceftazidime
Administration Route(s): INTRAMUSCULAR; INTRAVENOUS
Dosage Form(s): INJECTION, POWDER, FOR SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Ceftazidime

Product NDC: 25021-127
Labeler Name: Sagent Pharmaceuticals
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA062640
Marketing Category: ANDA
Start Marketing Date: 20080515

Package Information of Ceftazidime

Package NDC: 25021-127-20
Package Description: 25 VIAL in 1 CARTON (25021-127-20) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL

NDC Information of Ceftazidime

NDC Code 25021-127-20
Proprietary Name Ceftazidime
Package Description 25 VIAL in 1 CARTON (25021-127-20) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL
Product NDC 25021-127
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name ceftazidime
Dosage Form Name INJECTION, POWDER, FOR SOLUTION
Route Name INTRAMUSCULAR; INTRAVENOUS
Start Marketing Date 20080515
Marketing Category Name ANDA
Labeler Name Sagent Pharmaceuticals
Substance Name CEFTAZIDIME
Strength Number 1
Strength Unit g/1
Pharmaceutical Classes Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient]

Complete Information of Ceftazidime


General Information